CONCORD NEWS IN YOUR INBOX: SIGN UP HERE

Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY:BSX)

64.87 +5.35 (+8.99%)
Official Closing Price Updated: 7:00 PM EDT, Apr 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
News headline image
Stock Market Today, April 22: Boston Scientific Jumps After Q1 Earnings Beat Resets Growth Expectations ↗
On April 22, 2026, investors weigh a rare combo of earnings strength and softer long-term targets reshaping this medtech leader’s outlook. 
Via The Motley Fool
Topics Earnings Stocks
Discover which S&P500 stocks are making waves on Wednesday. ↗
Via Chartmill
Stay informed about the most active stocks in the S&P500 index on Wednesday's session. ↗
Via Chartmill
In today's session, there are S&P500 stocks with remarkable trading volume. ↗
Via Chartmill
Boston Scientific Corp (NYSE:BSX) Reports Mixed Q1 2026 Results, Slight Revenue Miss Amid Profit Beat ↗
Via Chartmill
Boston Scientific Corp (NYSE:BSX) Presents a Compelling Growth and Technical Setup Case ↗
Via Chartmill
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
News headline image
BSX Q2 2025 Earnings Transcript ↗
BSX Q2 2025 Earnings Transcript 
Via The Motley Fool
News headline image
BSX Q3 2025 Earnings Transcript ↗
BSX Q3 2025 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
BSX Q1 2026 Earnings Transcript ↗
BSX Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Economy World Trade
News headline image
Boston Scientific (NYSE:BSX) Surprises With Q1 CY2026 Sales
Medical device company Boston Scientific (NYSE:BSX) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 11.6% year on year to... 
Via StockStory
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines – BSX
From Pomerantz LLP
Via GlobeNewswire
News headline image
Boston Scientific Stock Is Trending Today: What To Know Now ↗
Boston Scientific Corp. (NYSE:BSX) shares are in the spotlight on Tuesday after Stifel maintained a Buy rating and lowered its price target on the stock. 
Via Benzinga
News headline image
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX)
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Boston Scientific (BSX) Q1 Earnings: What To Expect
Medical device company Boston Scientific (NYSE:BSX) will be reporting earnings this Wednesday before market hours. Here’s what you need to know. Boston Scien... 
Via StockStory
Topics Artificial Intelligence
News headline image
Robbins LLP Encourages BSX Stockholders to Contact the Firm for Information About the Class Action Against Boston Scientific
From Robbins LLP
Via Business Wire
Top S&P500 movers in Monday's session ↗
Via Chartmill
What's going on in today's session: S&P500 movers ↗
Via Chartmill
News headline image
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
1 Cash-Producing Stock for Long-Term Investors and 2 That Underwhelm
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
BSX INVESTOR ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Boston Scientific’s $14.9 Billion Bet: The Strategic "Homecoming" to Neurovascular Dominance
As of April 15, 2026, the medical technology landscape is bracing for its most significant transformation in years. Boston Scientific (NYSE:BSX) is moving steadily toward the finalization of its $14.9... 
Via MarketMinute
Topics Economy
News headline image
Consolidation Fever: Boston Scientific’s $14.9 Billion Bet on Penumbra Signals New Era in MedTech M&A
In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN) for approximately... 
Via MarketMinute
Topics Economy
News headline image
Wall Street’s Renaissance: Bank of America Shatters Q1 2026 Estimates as M&A and Trading Volatility Surge
The financial landscape of 2026 has been marked by a return to high-stakes deal-making and intense market fluctuations, and no institution seems more equipped to navigate this era than Bank of America... 
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
MedTech Surge and Oncology Resilience Drive Johnson & Johnson to Q1 Earnings Beat
In a resounding display of corporate resilience, Johnson & Johnson (NYSE:JNJ) reported first-quarter 2026 financial results that surpassed Wall Street expectations, signaling a successful navigation of... 
Via MarketMinute
Topics Bankruptcy Earnings Economy
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines – BSX
From Pomerantz LLP
Via GlobeNewswire
News headline image
Avanos Medical to be Acquired by American Industrial Partners for $1.27 Billion; Stock Surges 69%
The medical technology landscape witnessed a seismic shift on Tuesday as Avanos Medical (NYSE: AVNS) announced it has entered into a definitive agreement to be acquired by affiliates of American... 
Via MarketMinute
Topics Economy
News headline image
Johnson & Johnson Shatters Expectations in Q1 2026, Raising Full-Year Outlook as Healthcare Giant Pushes Toward $100 Billion Milestone
NEW BRUNSWICK, N.J. — In a powerful display of resilience and strategic execution, Johnson & Johnson (NYSE: JNJ) reported first-quarter 2026 financial results that exceeded Wall Street estimates across... 
Via MarketMinute
Topics Economy Intellectual Property
News headline image
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX)
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
The Great Consolidation: Q1 2026 M&A Activity Shatters Records Amid $3 Trillion Private Equity Surge
The global financial landscape underwent a seismic shift in the first quarter of 2026, as a "perfect storm" of stabilizing interest rates and technological urgency triggered a historic wave of mergers... 
Via MarketMinute
Topics Artificial Intelligence Economy
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Gift this article